- SG$17.47m
- SG$21.09m
- $43.78m
- 43
- 68
- 38
- 47
2019 June 30th | 2020 June 30th | 2021 June 30th | C2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 57.9 | 60.4 | 82.6 | 79.3 | 43.8 |
Cost of Revenue | |||||
Gross Profit | 18.2 | 18.1 | 27.1 | 24.6 | 12 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 52.1 | 55.6 | 71.3 | 72.2 | 45.3 |
Operating Profit | 5.76 | 4.78 | 11.3 | 7.16 | -1.52 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 5.73 | 4.63 | 11.1 | 6.86 | -1.97 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5.31 | 4.13 | 9.11 | 5.47 | -2.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 5.31 | 4.34 | 9.1 | 5.67 | -2.83 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5.31 | 4.34 | 9.1 | 5.67 | -2.83 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.064 | 0.052 | 0.102 | 0.074 | -0.033 |
Dividends per Share | |||||
Special Dividends per Share |